Valleylab™ Energy Portfolio Timeline

In New
And Exciting Ways

The Valleylab™ energy portfolio offers surgical solutions that are designed to bring consistency, reliability, and efficiency to procedures — we are evolving to drive higher levels of clinical and economic value.

We’re introducing technologies to advance patient care across more specialties, and partnering with providers in new and exciting ways. 

What’s new in the Valleylab™ Energy Portfolio?

LigaSure™ Vessel Sealing 

Our distinct technology drives confidence, consistency, and control. Trusted in 19 million procedures([FOOTNOTE=Based on internal report #US161132(1), Sales data from FY01-FY17. July 2017.  ],[ANCHOR=],[LINK=]) and counting. 

Valleylab™ Electrosurgery

Electrosurgery is grounded in patient safety with handheld instruments to return-electrode monitoring systems.

Valleylab™ Energy Platforms

Our intelligent energy platforms are designed to enhance performance.

Smoke Evacuation

Leading the way for OR health and safety.

Sonicision™ Ultrasonic Dissection

Cordless. Designed to improve freedom of movement in the OR.

BiZact™ Tonsillectomy Device

The BiZact™ device allows surgeons to remove tonsils efficiently([FOOTNOTE=Based on internal test report #RE00003687, Data collected during 17 procedures for product introduction. April–June 2017.],[ANCHOR=],[LINK=]),([FOOTNOTE=Lee SW, Jeon SS, Lee JD, Lee JY, Kim SC, Koh YW. A comparison of postoperative pain and complications in tonsillectomy using BiClamp forceps and electrocautery tonsillectomy. Otolaryngol Head Neck Surg. 2008;139(2):228-234.],[ANCHOR=],[LINK=]),([FOOTNOTE=Omrani M, Barati B, Omidifar N, Okhovvat AR, Hashemi SA. Coblation™* versus traditional tonsillectomy: A double blind randomized controlled trial. J Res Med Sci. 2012;17(1):45-50.],[ANCHOR=],[LINK=]),* — with less bleeding([FOOTNOTE=Shah UK, Galinkin J, Chiavacci R, Briggs M. Tonsillectomy by means of plasma-mediated ablation: prospective, randomized, blinded comparison with monopolar electrosurgery. Arch Otolaryngol Head Neck Surg. 2002;128(6):672-676.],[ANCHOR=],[LINK=]),([FOOTNOTE=Based on internal test report #RE00003687, Data collected during 17 procedures for product introduction. April–June 2017.],[ANCHOR=],[LINK=]),([FOOTNOTE=Roje Z, Racić G, Dogas Z, Pisac VP, Timms M. Postoperative morbidity and histopathologic characteristics of tonsillar tissue following coblation tonsillectomy in children: a prospective randomized single-blinded study.  Coll Antropol. 2009;33(1):293–298.],[ANCHOR=],[LINK=]),† and minimal thermal damage to tissue— so patients may experience less pain after surgery.([FOOTNOTE=Based on internal test report RE00015788 collected during Medtronic-sponsored tissue testing conducted on March 23, 2017.],[ANCHOR=],[LINK=]),([FOOTNOTE=Wilson YL, Merer DM, Moscatello AL. Comparison of three common tonsillectomy techniques: a prospective randomized, double-blinded clinical study. Laryngoscope. 2009;119(1):162–170.],[ANCHOR=],[LINK=]),([FOOTNOTE=Jones DT, Kenna MA, Guidi J, Huang L, Johnston PR, Licameli GR. Comparison of postoperative pain in pediatric patients undergoing coblation tonsillectomy versus cautery tonsillectomy.  Otolaryngol Head Neck Surg. 2011;144(6):972–977.],[ANCHOR=],[LINK=]),‡


Surgeons should have the tools they need to optimize patient outcomes. That’s why we’re building a portfolio of solutions designed to address specific clinical challenges across surgical specialties, including:

  · Bariatric
  · Colorectal
  · General
  · Gynecologic
  · Thoracic


A pursuit to improve clinical performance and absolute confidence in the quality and efficacy of our solutions. Adapting to — and helping shape — the changing healthcare landscape.

That’s why customers who standardize to the Valleylab™ energy portfolio get exclusive benefits, including:

  · LigaSure™ Performance Guarantee
  · REM Hold Harmless Agreement for Electrosurgery 
  · OR Collections Program

Innovating to Drive Performance.

We design systems to improve consistency, enhance performance, and redefine the standard of care.

Let’s work together to address the universal healthcare needs and improve patients’ lives, optimize costs and efficiencies, and expand global access. Join us in our mission to alleviate pain, restore health, and extend life worldwide.

Together, we can make a real difference in the global healthcare space.

  • * Used in 17 cases. Average procedure time for the BiZact™ tonsillectomy device was 9.35 min. compared to published literature stating 14.8 (pediatric) and 20.5 (adult) min. [Lee] for Electrocautery and 16.32 min. [Omrani] for Coblator™*

  • † Average intraoperative bleeding in 17 cases was 7.3 mL for BiZact™ device, compared to published literature results for Coblator™* device (10.83 mL) and electrocautery (27.08 mL) [Roje], and cold knife (73 mL) [Lachanas].

  • ‡ Low thermal damage has been shown in studies to result in less post-operative pain. The Bizact™ device has been shown to produce <1 mm thermal spread but has not been directly evaluated for pain reduction.